National Institute of Diabetes & Digestive & Kidney Diseases: Two Popular Diabetes Drugs Outperformed Others in Large Clinical Trial
September 22, 2022
September 22, 2022
BETHESDA, Maryland, Sept. 22 (TNSjou) -- The Department of Health and Human Services National Institute of Diabetes and Digestive and Kidney Diseases issued the following news release:
* * *
NIH-funded researchers complete first study comparing commonly used type 2 diabetes medications.
* * *
In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutid . . .
* * *
NIH-funded researchers complete first study comparing commonly used type 2 diabetes medications.
* * *
In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutid . . .